Director, Late Stage Clinical Development

Psychedelic Alpha; Myrtle Point (OR); On-site; USD 215,000 - 250,000; Full time

Benefits offered by this job

Health benefits (medical, dental, vis­

401(k) with company match

Generous PTO and parental leave

Job summary

Definium Therapeutics is seeking a Director of Late‑Stage Clinical Strategy to shape end‑to‑end Expanded Access and late‑stage programs across our portfolio. You will partner with Clinical Development, Regulatory, and Operations to ensure feasibility, regulatory readiness, and lifecycle alignment while guiding external collaborations with investigators and partners.

You will drive long‑term evidence generation, real‑world data plans, and post‑approval commitments, balancing strategic vision with

Qualifications

• Doctoral degree required (MD, PhD, PharmD, PsyD).
• 6–8+ years of clinical development experience in pharma/biotech.
• Proven experience leading Expanded Access and late‑stage programs.
• Experience managing third‑party vendors for program operations.
• CNS psychiatry experience strongly preferred.

Responsibilities

• Lead end‑to‑end strategy for Expanded Access Programs and late‑stage studies.
• Ensure programs are scientifically sound, regulator‑ready, and lifecycle aligned.
• Provide leadership across regulatory, clinical development, and operations.
• Collaborate with cross‑functional teams to ensure high‑quality execution.
• Engage external investigators and advisors to support objectives.

Skills

Expanded Access

Late-stage strategy

Cross-functional leadership

Regulatory strategy

Clinical operations

External engagement

Education

Doctoral degree

Job description

Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.

Our leadproductcandidate,lysergidetartrate(ourproprietary orally disintegrating tablet form oflysergide(LSD) D-tartrate),represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Our early stage pipeline includes DT402, the R-enantiomer of MDMA and is under development to target the core symptoms of autism spectrum disorder (ASD), specifically addressing social communication challenges.

Guided bythe recognitionthat patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to addresstheunderlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today’s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.

Together we are moving psychiatry forward-beyond better, into a boundless future. Join us!

The Director, Late-Stage Clinical Strategy will be responsible for theend-to-end strategy development, design, and execution of Expanded Access Programs and Late-Stage studies across Definium's portfolio. This leader will provide support to ensure programs are scientifically sound, operationally feasible, regulator-ready, and aligned with the integrated asset strategy, including lifecycle management, real-world evidence generation, and post-approval commitments.

This role requires both strategic leadership and hands-on execution, with the ability to operate effectively in a lean, fast‑moving organization.

Responsibilities

Strategic Leadership

• Lead aspects of the global strategy for Expanded Access Programs and Late- Stage development, aligned with asset lifecycle objectives, patient access goals, and regulatory expectations
• Partner with the Executive Director Late-Stage Clinical Strategy, Clinical Development, Clinical Operations, HEOR, Medical Affairs, Regulatory Affairs, Commercial, Asset Strategy Lead and Program Leadership to ensure Expanded Access Program and Late-Stage clinical activities are fully integrated into the overall asset strategy

Expanded Access Program Execution

• Lead the development and implementation of Expanded Access Programs, including protocol development, eligibility criteria, safety oversight, and operational execution
• Collaborate with cross-functional planning team to ensure Expanded Access Programs are compliant, scalable, ethically sound, and aligned with regulatory guidance
• Provide consultation to benefit-risk assessment, safety monitoring, and ongoing program evaluation

Late-Stage Strategy & Execution

• Support the development of the late-stage clinical evidence generation strategy objectives, including real-world evidence generation, long-term safety, effectiveness, and differentiation in the treatment landscape
• Lead the design, planning, and execution of the late-stage clinical evidence program, including protocol development, data collection strategies, and interpretation of outcomes for Phase 4 and investigator-initiated trials.
• Ensure late-stage clinical program designs address regulatory commitments, payer needs, and scientific gaps

Regulatory & Scientific Leadership

• Collaborate in the preparation and review of clinical content for regulatory submissions and interactions as applicable
• Provide clinical input into Investigator Brochures, clinical study reports, in collaboration with Regulatory Affairs

Cross-Functional & External Engagement

• Work collaboratively with Clinical Operations, Clinical Development, Data Management, Biostatistics, Pharmacovigilance, and Project Management to ensure high-quality execution
• Establish and maintain relationships with key investigators, advisors, and external experts to support EAP and late stage/potentially Phase 4 objectives
• Provide clinical leadership within matrix teams, modeling accountability, collaboration, and scientific rigor

Qualifications

Education & Experience

• Doctoral degree required (MD, PhD, PharmD, PsyD)
• 6-8+ years of clinical development experience in the pharmaceutical or biotechnology industry
• Demonstrated experience leading Expanded Access programs and late-stage, post-approval programs
• Experience selecting and managing third-party vendors to support operational functions of Expanded Access and late-stage evidence programs
• CNS clinical development experience in psychiatry strongly preferred
• Experience with budget ownership to include forecasting tracking, and managing across multiple programs

Skills & Competencies

• Working knowledge of expanded access program requirements, clinical development, regulatory pathways, and lifecycle management
• Proven ability to translate strategy into execution in resource-constrained environments
• Track record of effective cross-functional leadership and external stakeholder engagement
• Ability to operate with diplomacy, influence without authority, and command credibility with senior leaders and external experts
• Excellent verbal and written communication skills
• Self-motivated, adaptable, and comfortable balancing strategic thinking with hands-on contribution

Mindset & Fit

• Comfortable rolling up sleeves while maintaining a strategic perspective
• Energized by innovation in clinical research and patient‑centric access models
• Thrives in a fast‑paced, evolving environment with high accountability
• Acts as a role model for scientific excellence, integrity, and collaboration

The starting base pay range for this position is $215,000.00 - $250,000.00. Compensation will be determined based on several factors including, but not limited to, skill set, years of experience, and the employee’s geographic location.

Employees in this role may be entitled to additional compensation, including bonus and equity. Benefits information is listed on our Jobs Page. The Company provides competitive benefits to employees including:

• 100% paid health benefits including Medical, Dental and Vision for you and your dependents
• 401(k) program with company match and vesting after the turn of the first month after your start date
• Flexible time off
• Generous parental leave and some fun fringe perks!